ConductScience.org, home

Paper32808233

Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019.

De Sutter PJ and 6 others. Clin Pharmacokinet, 2020. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019. Papers, record 32808233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32808233

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019.
PubMed
Journal
Clin Pharmacokinet
PubMed
Year
2020
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.99
iCite
Revised in PubMed
2026-10-12
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1De Sutter PJPieter-Janhttps://orcid.org/0000-0003-3858-8017
2Gasthuys EElke
3Van Braeckel EEva
4Schelstraete PPetra
5Van Biervliet SStephanie
6Van Bocxlaer JJan
7Vermeulen AAn

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Pharmaceutical PreparationsMajor topic
PharmacokineticsMajor topic
Body Composition
Humans

References164

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111237938Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients.Am J Clin Nutr2001https://conductscience.org/library/papers/11237938PubMed
217216337Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients.Dig Dis Sci2007https://conductscience.org/library/papers/17216337PubMed
318511651Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.J Clin Pharmacol2008https://conductscience.org/library/papers/18511651PubMed
428335648Inflammation and pharmacokinetics: potential implications for HIV-infection.Expert Opin Drug Metab Toxicol2017https://conductscience.org/library/papers/28335648PubMed
523945604Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development.CPT Pharmacometrics Syst Pharmacol2013https://conductscience.org/library/papers/23945604PubMed
618079757Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery.Nat Rev Drug Discov2008https://conductscience.org/library/papers/18079757PubMed
716678035Therapeutic drug monitoring of prednisolone after lung transplantation.J Heart Lung Transplant2006https://conductscience.org/library/papers/16678035PubMed
814506027Population pharmacokinetics of ciprofloxacin in pediatric and adolescent patients with acute infections.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/14506027PubMed
914624363The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction.Pflugers Arch2004https://conductscience.org/library/papers/14624363PubMed
1030191579Liver Disease in Cystic Fibrosis: Illuminating the Black Box.Hepatology2019https://conductscience.org/library/papers/30191579PubMed
1110485301Effect of elective antibiotic therapy on resting energy expenditure and inflammation in cystic fibrosis.Eur J Pediatr1999https://conductscience.org/library/papers/10485301PubMed
1212548141Bayesian forecasting of oral cyclosporin pharmacokinetics in stable lung transplant recipients with and without cystic fibrosis.Ther Drug Monit2003https://conductscience.org/library/papers/12548141PubMed
1323887688Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods.CPT Pharmacometrics Syst Pharmacol2013https://conductscience.org/library/papers/23887688PubMed
1417485505Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17485505PubMed
1517576827Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17576827PubMed
1623357842
Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosis.
Int J Clin Pharmacol Ther2013https://conductscience.org/library/papers/23357842PubMed
1711396809Assessment of hepatic function in cystic fibrosis by lidocaine metabolism.J Pediatr Gastroenterol Nutr2001https://conductscience.org/library/papers/11396809PubMed
189812180Drug disposition in cystic fibrosis.Clin Pharmacokinet1998https://conductscience.org/library/papers/9812180PubMed
193286083Clinical pharmacokinetics of aztreonam.Clin Pharmacokinet1988https://conductscience.org/library/papers/3286083PubMed
209174484Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation.Am J Clin Nutr1997https://conductscience.org/library/papers/9174484PubMed

See all 164 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42897405Predictive Performance of pyDarwin-Selected Versus Expert-Developed Paediatric Tobramycin Population Pharmacokinetic Models for Model-Informed Precision Dosing.AAPS J2026https://conductscience.org/library/papers/42897405PubMed
42170795Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42170795PubMed
40957819Evaluation of the drug interaction between rifabutin and elexacaftor/tezacaftor/ivacaftor (ETI).J Cyst Fibros2026https://conductscience.org/library/papers/40957819PubMed
40698812Personalized tobramycin dosing in children with cystic fibrosis: an AUC24-guided approach.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40698812PubMed
40312342Clinical Study Reports-a systematic review with thematic synthesis: Part 2. Studying benefits, harms, and the benefit to harm balance of pharmacological interventions.Trials2025https://conductscience.org/library/papers/40312342PubMed
40254714Anti-infectives in Pediatric Patients with Cystic Fibrosis: A Comprehensive Review of Population Pharmacokinetic Analyses.Clin Pharmacokinet2025https://conductscience.org/library/papers/40254714PubMed
40142982Evaluation of Complex Drug Interactions Between Elexacaftor-Tezacaftor-Ivacaftor and Statins Using Physiologically Based Pharmacokinetic Modeling.Pharmaceutics2025https://conductscience.org/library/papers/40142982PubMed
39846711The Pharmacokinetic Changes in Cystic Fibrosis Patients Population: Narrative Review.Medicines (Basel)2024https://conductscience.org/library/papers/39846711PubMed
39581957Pharmacokinetics of Omadacycline in Adults with Cystic Fibrosis.Clin Pharmacokinet2024https://conductscience.org/library/papers/39581957PubMed
39526586Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis.Pediatr Pulmonol2025https://conductscience.org/library/papers/39526586PubMed
38303579Physiologically-based pharmacokinetic modeling of the drug-drug interaction between ivacaftor and lefamulin in cystic fibrosis patients.CPT Pharmacometrics Syst Pharmacol2024https://conductscience.org/library/papers/38303579PubMed
37760696Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model.Antibiotics (Basel)2023https://conductscience.org/library/papers/37760696PubMed
37148427MicroRNAs from Holarrhena pubescens stems: Identification by small RNA Sequencing and their Potential Contribution to Human Gene Targets.Funct Integr Genomics2023https://conductscience.org/library/papers/37148427PubMed
36565357Linezolid pharmacokinetics: a systematic review for the best clinical practice.Eur J Clin Pharmacol2023https://conductscience.org/library/papers/36565357PubMed
35748042Altered intravenous drug disposition in people living with cystic fibrosis: A meta-analysis integrating top-down and bottom-up data.CPT Pharmacometrics Syst Pharmacol2022https://conductscience.org/library/papers/35748042PubMed
35625789Gene Polymorphism of Biotransformation Enzymes and Ciprofloxacin Pharmacokinetics in Pediatric Patients with Cystic Fibrosis.Biomedicines2022https://conductscience.org/library/papers/35625789PubMed
35292968Physiologically-Based Pharmacokinetic-Led Guidance for Patients With Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor With Nirmatrelvir-Ritonavir for the Treatment of COVID-19.Clin Pharmacol Ther2022https://conductscience.org/library/papers/35292968PubMed
35280373Population pharmacokinetics of polymyxin B: a systematic review.Ann Transl Med2022https://conductscience.org/library/papers/35280373PubMed
35214140Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients.Pharmaceutics2022https://conductscience.org/library/papers/35214140PubMed
35119624"De-Shrinking" EBEs: The Solution for Bayesian Therapeutic Drug Monitoring.Clin Pharmacokinet2022https://conductscience.org/library/papers/35119624PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32808233

GET https://conductscience.org/api/papers/v1/32808233/references?page=2